• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

世界知识产权组织研究项目：通过跨部门伙伴关系加速驱虫药研发。

WIPO Re:Search: Accelerating anthelmintic development through cross-sector partnerships.

作者信息

Ramamoorthi Roopa, Graef Katy M, Dent Jennifer

机构信息

BIO Ventures for Global Health, 401 Terry Avenue North, Seattle, WA 98109, United States.

出版信息

Int J Parasitol Drugs Drug Resist. 2014 Sep 19;4(3):220-5. doi: 10.1016/j.ijpddr.2014.09.002. eCollection 2014 Dec.

DOI:10.1016/j.ijpddr.2014.09.002
PMID:25516832
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4266808/
Abstract

Neglected tropical diseases (NTDs), malaria, and tuberculosis have a devastating effect on an estimated 1.6 billion people worldwide. The World Intellectual Property Organization (WIPO) Re:Search consortium accelerates the development of new drugs, vaccines, and diagnostics for these diseases by connecting the assets and resources of pharmaceutical companies, such as compound libraries and expertise, to academic or nonprofit researchers with novel product discovery or development ideas. As the WIPO Re:Search Partnership Hub Administrator, BIO Ventures for Global Health (BVGH) fields requests from researchers, identifies Member organizations able to fulfill these requests, and helps forge mutually beneficial collaborations. Since its inception in October 2011, WIPO Re:Search membership has expanded to more than 90 institutions, including leading pharmaceutical companies, universities, nonprofit research institutions, and product development partnerships from around the world. To date, WIPO Re:Search has facilitated over 70 research agreements between Consortium Members, including 11 collaborations focused on anthelmintic drug discovery.

摘要

被忽视的热带病、疟疾和结核病对全球约16亿人造成了毁灭性影响。世界知识产权组织（WIPO）Re:Search联盟通过将制药公司的资产和资源（如化合物库和专业知识）与拥有新产品发现或开发想法的学术或非营利研究人员相连接，加速了针对这些疾病的新药、疫苗和诊断方法的开发。作为WIPO Re:Search伙伴关系中心管理员，全球健康生物 Ventures（BVGH）处理研究人员的请求，确定能够满足这些请求的成员组织，并帮助促成互利合作。自2011年10月成立以来，WIPO Re:Search的成员已扩展到90多个机构，包括全球领先的制药公司、大学、非营利研究机构和产品开发伙伴关系组织。迄今为止，WIPO Re:Search已促成联盟成员之间达成70多项研究协议，其中包括11项专注于驱虫药物发现的合作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336d/4266808/06e6a8169a14/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336d/4266808/c52dd4c892b3/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336d/4266808/b310a9bfa57b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336d/4266808/06e6a8169a14/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336d/4266808/c52dd4c892b3/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336d/4266808/b310a9bfa57b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/336d/4266808/06e6a8169a14/gr2.jpg

相似文献

1
WIPO Re:Search: Accelerating anthelmintic development through cross-sector partnerships.世界知识产权组织研究项目：通过跨部门伙伴关系加速驱虫药研发。
Int J Parasitol Drugs Drug Resist. 2014 Sep 19;4(3):220-5. doi: 10.1016/j.ijpddr.2014.09.002. eCollection 2014 Dec.
2
WIPO Re:Search: Catalyzing Public-Private Partnerships to Accelerate Tropical Disease Drug Discovery and Development.世界知识产权组织研究项目：促进公私伙伴关系以加速热带病药物的研发。
Trop Med Infect Dis. 2019 Mar 26;4(1):53. doi: 10.3390/tropicalmed4010053.
3
WIPO Re:Search-A Platform for Product-Centered Cross-Sector Partnerships for the Elimination of Schistosomiasis.世界知识产权组织研究项目——一个以产品为中心的跨部门消除血吸虫病伙伴关系平台。
Trop Med Infect Dis. 2019 Jan 9;4(1):11. doi: 10.3390/tropicalmed4010011.
4
Fostering innovative product development for neglected tropical diseases through partnerships.通过伙伴关系促进被忽视热带病的创新产品开发。
Pharm Pat Anal. 2016 Sep;5(6):391-400. doi: 10.4155/ppa-2016-0038. Epub 2016 Nov 4.
5
WIPO Re:Search: a consortium catalyzing research and product development for neglected tropical diseases.世界知识产权组织研究协作项目：一个推动被忽视热带病研究与产品开发的联盟。
Pharm Pat Anal. 2013 Sep;2(5):591-6. doi: 10.4155/ppa.13.49.
6
[International Partnership for Therapeutic Drug Development of NTDs by DNDi].[被忽视热带病药物开发全球合作组织（DNDi）的国际治疗药物开发伙伴关系]
Yakugaku Zasshi. 2016;136(2):213-22. doi: 10.1248/yakushi.15-00233-2.
7
New Vaccines for the World's Poorest People.为世界最贫困人口研发新疫苗。
Annu Rev Med. 2016;67:405-17. doi: 10.1146/annurev-med-051214-024241. Epub 2015 Sep 3.
8
[Partnership Activity for Neglected Tropical Diseases].[被忽视热带病伙伴关系活动]
Yakugaku Zasshi. 2022;142(7):697-701. doi: 10.1248/yakushi.21-00210-3.
9
[Corporate Efforts to Research and Develop Therapeutic Agents for Infectious Diseases That Threaten Human].[企业为研发针对威胁人类的传染病治疗药物所做的努力]
Yakugaku Zasshi. 2022;142(7):691-696. doi: 10.1248/yakushi.21-00210-2.
10
The Importance of Collaboration between Industry, Academics, and Nonprofits in Tropical Disease Drug Discovery.产业界、学术界和非营利组织在热带病药物研发中合作的重要性。
ACS Infect Dis. 2018 Apr 13;4(4):445-448. doi: 10.1021/acsinfecdis.7b00208. Epub 2017 Nov 14.

引用本文的文献

1
Prediction and Prioritisation of Novel Anthelmintic Candidates from Public Databases Using Deep Learning and Available Bioactivity Data Sets.利用深度学习和现有生物活性数据集从公共数据库中预测新型驱虫候选物并进行优先级排序。
Int J Mol Sci. 2025 Mar 28;26(7):3134. doi: 10.3390/ijms26073134.
2
Chemical modulation of lysine specific demethylase 1 (SmLSD1) induces wide-scale biological and epigenomic changes.赖氨酸特异性去甲基化酶1（SmLSD1）的化学调控诱导广泛的生物学和表观基因组变化。
Wellcome Open Res. 2023 Mar 30;8:146. doi: 10.12688/wellcomeopenres.18826.1. eCollection 2023.
3
Thermal proteome profiling reveals orphan protein HCO_011565 as a target of the nematocidal small molecule UMW-868.

本文引用的文献

1
WIPO re:search: catalyzing collaborations to accelerate product development for diseases of poverty.世界知识产权组织研究计划：促成合作以加速针对贫困相关疾病的产品开发。
Chem Rev. 2014 Nov 26;114(22):11272-9. doi: 10.1021/cr5000656. Epub 2014 Sep 17.
2
The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases.《2010年全球疾病负担研究：对被忽视热带病的解读与影响》
PLoS Negl Trop Dis. 2014 Jul 24;8(7):e2865. doi: 10.1371/journal.pntd.0002865. eCollection 2014 Jul.
3
Controversies and challenges in research on urogenital schistosomiasis-associated bladder cancer.
热蛋白质组分析揭示孤儿蛋白HCO_011565是杀线虫小分子UMW-868的靶点。
Front Pharmacol. 2022 Oct 14;13:1014804. doi: 10.3389/fphar.2022.1014804. eCollection 2022.
4
Point of Care Diagnostics in Resource-Limited Settings: A Review of the Present and Future of PoC in Its Most Needed Environment.资源有限环境下的即时诊断检测：即时检测在最急需的环境中的现状和未来综述。
Biosensors (Basel). 2020 Sep 24;10(10):133. doi: 10.3390/bios10100133.
5
Where are all the anthelmintics? Challenges and opportunities on the path to new anthelmintics.驱虫剂都去哪儿了？在寻找新驱虫剂的道路上面临的挑战与机遇。
Int J Parasitol Drugs Drug Resist. 2020 Dec;14:8-16. doi: 10.1016/j.ijpddr.2020.07.001. Epub 2020 Jul 29.
6
Anthelmintic drug discovery: target identification, screening methods and the role of open science.抗寄生虫药物发现：靶点识别、筛选方法及开放科学的作用
Beilstein J Org Chem. 2020 Jun 2;16:1203-1224. doi: 10.3762/bjoc.16.105. eCollection 2020.
7
The repositioning of epigenetic probes/inhibitors identifies new anti-schistosomal lead compounds and chemotherapeutic targets.表观遗传探针/抑制剂的重定位确定了新的抗血吸虫先导化合物和化疗靶标。
PLoS Negl Trop Dis. 2019 Nov 15;13(11):e0007693. doi: 10.1371/journal.pntd.0007693. eCollection 2019 Nov.
8
An Abies procera-derived tetracyclic triterpene containing a steroid-like nucleus core and a lactone side chain attenuates in vitro survival of both Fasciola hepatica and Schistosoma mansoni.一种来源于白皮松的四环三萜，含有甾体样核芯和内酯侧链，可在体外抑制肝片吸虫和曼氏血吸虫的存活。
Int J Parasitol Drugs Drug Resist. 2018 Dec;8(3):465-474. doi: 10.1016/j.ijpddr.2018.10.009. Epub 2018 Oct 26.
9
Anthelmintics - from discovery to resistance.驱虫药——从发现到抗药性
Int J Parasitol Drugs Drug Resist. 2014 Nov 22;4(3):218-9. doi: 10.1016/j.ijpddr.2014.10.001. eCollection 2014 Dec.
尿生殖型血吸虫病相关膀胱癌研究中的争议和挑战。
Trends Parasitol. 2014 Jul;30(7):324-32. doi: 10.1016/j.pt.2014.05.004. Epub 2014 Jun 6.
4
A new mouse model for female genital schistosomiasis.一种用于女性生殖器血吸虫病的新型小鼠模型。
PLoS Negl Trop Dis. 2014 May 1;8(5):e2825. doi: 10.1371/journal.pntd.0002825. eCollection 2014 May.
5
Randomized, controlled, assessor-blind clinical trial to assess the efficacy of single- versus repeated-dose albendazole to treat ascaris lumbricoides, trichuris trichiura, and hookworm infection.一项随机、对照、评估者盲法的临床试验，旨在评估单剂量与重复剂量阿苯达唑治疗蛔虫、鞭虫和钩虫感染的疗效。
Antimicrob Agents Chemother. 2014 May;58(5):2535-40. doi: 10.1128/AAC.01317-13. Epub 2014 Feb 18.
6
Global numbers of infection and disease burden of soil transmitted helminth infections in 2010.2010 年全球土壤传播性蠕虫感染的感染人数和疾病负担。
Parasit Vectors. 2014 Jan 21;7:37. doi: 10.1186/1756-3305-7-37.
7
Nature Bank and the Queensland Compound Library: unique international resources at the Eskitis Institute for Drug Discovery.自然库与昆士兰化合物库：埃斯基蒂斯药物研发研究所的独特国际资源。
Comb Chem High Throughput Screen. 2014 Mar;17(3):201-9. doi: 10.2174/1386207317666140109120515.
8
MDGs and NTDs: reshaping the global health agenda.千年发展目标与被忽视的热带病：重塑全球卫生议程
PLoS Negl Trop Dis. 2013 Dec 12;7(12):e2529. doi: 10.1371/journal.pntd.0002529. eCollection 2013.
9
WIPO Re:Search: a consortium catalyzing research and product development for neglected tropical diseases.世界知识产权组织研究协作项目：一个推动被忽视热带病研究与产品开发的联盟。
Pharm Pat Anal. 2013 Sep;2(5):591-6. doi: 10.4155/ppa.13.49.
10
Human soil-transmitted helminths: implications of mass drug administration.人体土壤传播性蠕虫：大规模药物治疗的影响。
Curr Opin Infect Dis. 2012 Dec;25(6):703-8. doi: 10.1097/QCO.0b013e328358993a.